In Liverpool, the use of NHS concentrate increased in 1983. Read more about In Liverpool, the use of NHS concentrate increased in 1983.
At a Mersey RTC meeting, there was no discussion at all about the issue of AIDS. Read more about At a Mersey RTC meeting, there was no discussion at all about the issue of AIDS.
Small amounts of cryoprecipitate were used with NHS concentrate and commercial concentrates were used in substantial amounts at the Leeds Haemophilia Centre. Read more about Small amounts of cryoprecipitate were used with NHS concentrate and commercial concentrates were used in substantial amounts at the Leeds Haemophilia Centre.
1,497,585 units of NHS Factor 8 and 1,715,894 units of commercial concentrates were used at the Leeds Haemophilia Centre. Read more about 1,497,585 units of NHS Factor 8 and 1,715,894 units of commercial concentrates were used at the Leeds Haemophilia Centre.
Whilst the volume of NHS concentrate used at the Leeds Haemophilia Centre increased in 1983, a very substantial amount of commercial concentrate continued to be used. Read more about Whilst the volume of NHS concentrate used at the Leeds Haemophilia Centre increased in 1983, a very substantial amount of commercial concentrate continued to be used.
Dr Colvin reported that, at London Hospital Haemophilia Centre, there were 41 patients infected with HIV, of whom 31 had severe Haemophilia A, 9 had moderate/mild Haemophilia A and 1 had Haemophilia B. He recalled three children who were infected with HIV from their treatment and one partner of a patient who was infected. Read more about Dr Colvin reported that, at London Hospital Haemophilia Centre, there were 41 patients infected with HIV, of whom 31 had severe Haemophilia A, 9 had moderate/mild Haemophilia A and 1 had Haemophilia B. He recalled three children who were infected with HIV from their treatment and one partner of a patient who was infected.
It was stated that "until a positive test for AIDS and/or a vaccine is developed it should be policy to avoid use of blood products except for essential treatments and to use cryoprecipitate or plasma instead of FVIII Concentrate whenever possible." Read more about It was stated that "until a positive test for AIDS and/or a vaccine is developed it should be policy to avoid use of blood products except for essential treatments and to use cryoprecipitate or plasma instead of FVIII Concentrate whenever possible."
Dr Colvin wrote that they knew little about AIDS at this time. The health service should not "spurn" commercial concentrate as they must stay aware of the risks associated with NHS material. Read more about Dr Colvin wrote that they knew little about AIDS at this time. The health service should not "spurn" commercial concentrate as they must stay aware of the risks associated with NHS material.
In reference to the risks of AIDS in haemophilia services, possible complications in treatment were described as "Plasma product-transmitted disease, particularly hepatitis and (possibly) the acquired immune deficiency syndrome (AIDS)" Read more about In reference to the risks of AIDS in haemophilia services, possible complications in treatment were described as "Plasma product-transmitted disease, particularly hepatitis and (possibly) the acquired immune deficiency syndrome (AIDS)"
A reduction in the purchase of commercial concentrate in 1983 was due to an increase in supply of NHS material demonstrating Dr Colvin's intent to minimise risk where and when it was sensible to do so. Read more about A reduction in the purchase of commercial concentrate in 1983 was due to an increase in supply of NHS material demonstrating Dr Colvin's intent to minimise risk where and when it was sensible to do so.